A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants
- PMID: 32135162
- PMCID: PMC7188583
- DOI: 10.1016/j.jim.2020.112766
A new cell line for assessing HIV-1 antibody dependent cellular cytotoxicity against a broad range of variants
Abstract
Human immunodeficiency virus type 1 (HIV-1) studies suggest that antibody-dependent cellular cytotoxicity (ADCC) influences both virus acquisition and subsequent disease outcome. Technical issues with currently available assays, however, have limited the ability to comprehensively assess the impact of ADCC on transmission and disease progression. Commonly used ADCC assays use a target cell line, CEM.NKr-CCR5-Luc, that often does not support replication of relevant HIV-1 variants. Thus, the extent of ADCC responses against a large panel of HIV-1 strains often cannot be assessed using the currently available methods. We developed two new reporter cell-lines (MT4-CCR5-Luc and PM1-CCR5-Luc) to overcome these issues. MT4-CCR5-Luc cells are resistant, whereas PM1-CCR5-Luc cells are susceptible, to killing by a natural killer cell line, CD16+KHYG-1, in the absence of antibody. Polyclonal HIVIG gave similar ADCC estimates against HIV-1 isolate, NL4-3, regardless of which of the three cell lines were used as the targets. In contrast to CEM.NKr-CCR5-Luc and PM1-CCR5-Luc, however, MT4-CCR5-Luc target cells produce significantly higher luciferase after exposure to various HIV-1 strains, including transmitted founder variants and viruses incorporating specific envelopes of interest. This higher luciferase expression does not yield spurious results because ADCC estimates are similar when killing is assessed by both reporter protein expression and flow cytometry. Furthermore, ADCC estimates derived from MT4-CCR5-Luc cells are not skewed by non-antibody contents present in human plasma. In aggregate, the MT4-CCR5-Luc cell line can be used to estimate monoclonal antibody or plasma-induced ADCC responses against a diverse range of HIV-1 envelopes relevant for transmission and disease progression studies.
Keywords: Antibody dependent cellular cytotoxicity; Envelope; Human immunodeficiency virus type 1.
Copyright © 2020 Elsevier B.V. All rights reserved.
Figures







Similar articles
-
Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.J Virol. 2018 Jun 13;92(13):e00484-18. doi: 10.1128/JVI.00484-18. Print 2018 Jul 1. J Virol. 2018. PMID: 29669829 Free PMC article.
-
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.J Virol. 2022 Jan 26;96(2):e0164321. doi: 10.1128/JVI.01643-21. Epub 2021 Nov 3. J Virol. 2022. PMID: 34730393 Free PMC article.
-
Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.J Virol. 2016 Jun 10;90(13):6127-6139. doi: 10.1128/JVI.00347-16. Print 2016 Jul 1. J Virol. 2016. PMID: 27122574 Free PMC article.
-
Unlocking HIV-1 Env: implications for antibody attack.AIDS Res Ther. 2017 Sep 12;14(1):42. doi: 10.1186/s12981-017-0168-5. AIDS Res Ther. 2017. PMID: 28893275 Free PMC article. Review.
-
HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.Expert Rev Clin Immunol. 2012 Nov;8(8):767-74. doi: 10.1586/eci.12.74. Expert Rev Clin Immunol. 2012. PMID: 23167688 Review.
Cited by
-
Mycobacterium tuberculosis disease associates with higher HIV-1-specific antibody responses.iScience. 2023 Apr 10;26(5):106631. doi: 10.1016/j.isci.2023.106631. eCollection 2023 May 19. iScience. 2023. PMID: 37168567 Free PMC article.
-
Antibody-dependent cellular cytotoxicity responses and susceptibility influence HIV-1 mother-to-child transmission.JCI Insight. 2022 May 9;7(9):e159435. doi: 10.1172/jci.insight.159435. JCI Insight. 2022. PMID: 35324477 Free PMC article.
-
Pre-existing infant antibody-dependent cellular cytotoxicity associates with reduced HIV-1 acquisition and lower morbidity.Cell Rep Med. 2021 Oct 19;2(10):100412. doi: 10.1016/j.xcrm.2021.100412. eCollection 2021 Oct 19. Cell Rep Med. 2021. PMID: 34755132 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials